Vanovian Bio builds AI-powered tools for life science professionals and develops novel oncology therapeutics — one studio, two missions.
Get in touchWe operate as a venture studio with two complementary programs — an AI-powered evidence platform that drives the intelligence behind our oncology therapeutics R&D.
AI-powered search and synthesis for biomedical evidence. Our platform searches PubMed, ClinicalTrials.gov, and academic databases simultaneously, scoring and ranking results with audience-specific lenses for Medical Affairs, Regulatory, and R&D professionals.
Stealth-mode small molecule oncology program exploring tumor microenvironment modulation. Focused on novel approaches to enhance existing radiation and immunotherapy regimens through rational drug repurposing and mechanistic insight.
What we learn powers what we build. What we build powers what we learn.
Immunologist and cancer researcher with experience spanning pre-clinical oncology, gene therapy, and translational biology. Previously at Ensoma (Boston) leading IND-enabling studies for novel gene therapy platforms. PhD research at the University of Guelph in cancer biotherapeutics and viral immunotherapy.
Whether you're in Medical Affairs, pharma R&D, consulting, or investing in life sciences — we'd love to hear from you.
rob@vanovianbio.com